Post by Boston Scientific on X
Boston Scientific@bostonsci
XFurther expansion of our cardiovascular portfolio includes today’s announcement that we’ve agreed to acquire SoniVie, developer of an intravascular ultrasound system designed to perform renal artery denervation for the treatment of hypertension. t.co
25 likes4 repliesPosted Mar 3, 2025